Impacts of chemicals on liver cancer risk
- 1 June 2000
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 10 (3) , 201-210
- https://doi.org/10.1006/scbi.2000.0320
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1Hepatology, 1999
- Protective Alterations in Phase 1 and 2 Metabolism of Aflatoxin B1 by Oltipraz in Residents of Qidong, People's Republic of ChinaJNCI Journal of the National Cancer Institute, 1999
- Hepatitis viruses and hepatocellular carcinomaResearch in Virology, 1998
- Mutational properties of the primary aflatoxin B1-DNA adduct.Proceedings of the National Academy of Sciences, 1996
- Epigenetic carcinogens: Evaluation and risk assessmentExperimental and Toxicologic Pathology, 1996
- Geographic Variation of p53 Mutational Profile in Nonmalignant Human LiverScience, 1994
- Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.Proceedings of the National Academy of Sciences, 1993
- DNA conformation mediates aflatoxin B1-DNA binding and the formation of guanine N7 adducts by aflatoxin B1 8,9-exo-epoxideChemical Research in Toxicology, 1993